Holen Sie sich die Stockscreener-App
240.00
1.46%
-3.56
Handel nachbörslich:
240.00
Schlusskurs vom Vortag:
$243.56
Offen:
$242.7
24-Stunden-Volumen:
348.06K
Relative Volume:
1.32
Marktkapitalisierung:
$6.68B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-8.7816
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
-2.96%
1M Leistung:
-9.49%
6M Leistung:
-28.93%
1J Leistung:
-29.20%
1-Tages-Spanne:
$237.92
$245.52
1-Wochen-Bereich:
$235.84
$249.37
52-Wochen-Spanne:
$235.84
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
240.00 | 6.68B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
131.69 | 228.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.24 | 149.58B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
373.30 | 142.54B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.49 | 113.81B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.87 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Autoimmune Disease Diagnostics Market Is Booming So Rapidly - openPR.com
Cell-Free Protein Expression Market Detailed Analysis - openPR.com
Dna Sequencing Equipment And Services Market 2025: Sustainable - openPR.com
Biomarker Research Services Market Is Booming Worldwide - openPR.com
Porphyria Treatment Market Growth in Future Scope 2025-2032 | - openPR.com
Jefferies cuts Bio-Rad Labs target to $285, maintains Hold By Investing.com - Investing.com Canada
Life Science Products Market Projected To Witness Substantial - openPR
HIV Diagnostics Test Market Projected To Witness Substantial - openPR
Cancer Biomarkers Market: Emerging Trends, Growth Drivers & - openPR
Bio-Rad stock touches 52-week low at $243.94 amid market shifts By Investing.com - Investing.com South Africa
Bio-Rad stock touches 52-week low at $243.94 amid market shifts - Investing.com Australia
Chromatography Data System Market Generated Opportunities, - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Flow Cytometry Market Is Booming Worldwide | Luminex - openPR
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund - MSN
Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed - MSN
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts -March 24, 2025 at 04:06 pm EDT - Marketscreener.com
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts - StreetInsider.com
Oncocyte Secures Game-Changing Bio-Rad Deal and $57M War Chest for $1B Market Push - StockTitan
Clinical Diagnostics Market is Projected to Increase at a CAGR - openPR
Monoclonal Antibody Diagnostic Reagents Market Growth - openPR
Oncocyte secures $29.1 million to advance FDA assay - MSN
Bio-Rad Launches XP-Design Assay Salmonella Serotyping Solution for Food Safety Testing - Technology Networks
Enzyme Linked Immunosorbent Assay Market Growth Analysis: - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Life Science Products Market Is Booming Worldwide 2025-2032 | - openPR
Hemoglobin A1c Testing Devices Market Projected To Witness - openPR
Learn to Evaluate (BIO) using the Charts - Stock Traders Daily
Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? - simplywall.st
Cancer Biomarkers Market Size, Share, Growth Factors, - openPR
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Blotting Machine Market Future Business Opportunities - openPR
Where are the Opportunities in (BIO.B) - Stock Traders Daily
The Future of Genetic Testing: Industry Growth, Trends & Key - openPR
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Bio-Rad Laboratories, - EIN News
Transcriptomics Technologies Market Future Business - openPR
Salmonella serotyping solution enhances food safety testing - Labmate Online
New XP-Design Assay Salmonella Serotyping Solution for Rapid, Accurate Food Safety Testing - Food Safety Magazine
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing - Cambridge Network
Newborn Screening Market Growth in Future Scope 2025-2032 | - openPR
Charles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Laboratory Supplies Market Generated Opportunities, Future - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
ChemiDoc Go Imaging System - the-scientist.com
HIV Rapid Test Kits Market Focused Insights 2025-2030: Abbott, Bio-Rad, and bioMerieux Strengthen Market Position Amid Rising Competition - Yahoo Finance
Stem Cell Assay Market Demand, Industry Growth and Future Scope - openPR
Empowering Growth: Vector Purification Market 2025 - openPR
Clinical Biomarkers Market Key Players Analysis- Johnson & - openPR
Expanded kit range enhances AAV vector characterisation - Labmate Online
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):